Russell OM, Gorman GS, Lightowlers RN, Turnbull DM. Mitochondrial diseases: Hope for the future. Cell. 2020;181:168–88.

Article  CAS  PubMed  Google Scholar 

Li D, Liang C, Zhang T, Marley JL, Zou W, Lian M, Ji D. Pathogenic mitochondrial DNA 3243A>G mutation: From genetics to phenotype. Front Genet. 2022;13: 951185.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ng YS, Lax NZ, Blain AP, Erskine D, Baker MR, Polvikoski T, Thomas RH, Morris CM, Lai M, Whittaker RG, Gebbels A, Winder A, Hall J, Feeney C, Farrugia ME, Hirst C, Roberts M, Lawthom C, Chrysostomou A, Murphy K, Baird T, Maddison P, Duncan C, Poulton J, Nesbitt V, Hanna MG, Pitceathly RDS, Taylor RW, Blakely EL, Schaefer AM, Turnbull DM, McFarland R, Gorman GS. Forecasting stroke-like episodes and outcomes in mitochondrial disease. Brain. 2022;145:542–54.

Article  PubMed  Google Scholar 

Martens AM, Gorter H, Wassink RG, Rietman H. Physical activity of children with a mitochondrial disease compared to children who are healthy. Pediatr Phys Ther. 2014;26:19–26.

Article  PubMed  Google Scholar 

Ohsawa Y, Hagiwara H, Nishimatsu SI, Hirakawa A, Kamimura N, Ohtsubo H, Fukai Y, Murakami T, Koga Y, Goto YI, Ohta S, Sunada Y; KN01 Study Group. Taurine supplementation for prevention of stroke-like episodes in MELAS: A multicentre, open-label, 52-week phase III trial. J Neurol Neurosurg Psychiatry. 2019;90:529–36.

Gorman GS, Schaefer AM, Ng Y, Gomez N, Blakely EL, Alston CL, Feeney C, Horvath R, Yu-Wai-Man P, Chinnery PF, Taylor RW, Turnbull DM, McFarland R. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol. 2015;77:753–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Edmonds JL, Kirse DJ, Kearns D, Deutsch R, Spruijt L, Naviaux RK. The otolaryngological manifestations of mitochondrial disease and the risk of neurodegeneration with infection. Arch Otolaryngol Head Neck Surg. 2002;128:355–62.

Article  PubMed  Google Scholar 

Wallace DC, Chalkia D. Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harb Perspect Biol. 2013;5: a021220.

Article  PubMed  PubMed Central  Google Scholar 

Nissanka N, Moraes CT. Mitochondrial DNA heteroplasmy in disease and targeted nuclease-based therapeutic approaches. EMBO Rep. 2020;21: e49612.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bakis H, Trimouille A, Vermorel A, Goizet C, Belaroussi Y, Schutz S, Solé G, Combe C, Martin-Negrier ML, Rigothier C. Renal involvement is frequent in adults with primary mitochondrial disorders: An observational study. Clin Kidney J. 2022;16:100–10.

Article  PubMed  PubMed Central  Google Scholar 

Imasawa T, Hirano D, Nozu K, Kitamura H, Hattori M, Sugiyama H, Sato H, Murayama K; J-SmiN Collaborators. Clinicopathologic features of mitochondrial nephropathy. Kidney Int Rep. 2022;7:580–90.

Thurlow JS, Joshi M, Yan G, Norris KC, Agodoa LY, Yuan CM, Nee R. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol. 2021;52:98–107.

Article  PubMed  Google Scholar 

Kobayashi A, Goto Y, Nagata M, Yamaguchi Y. Granular swollen epithelial cells: a histologic and diagnostic marker for mitochondrial nephropathy. Am J Surg Pathol. 2010;34:262–70.

Article  PubMed  Google Scholar 

Ochiai S, Inagaki H, Hisanaga S, Tanaka H, Kikuchi M, Fujimoto S. A patient with mitochondrial disease on dialysis with long-term follow-up of cardiomyopathy: An autopsy case report. Intern Med. 2023;62:2859–63.

Article  PubMed  PubMed Central  Google Scholar 

Maassen JA, T Hart LM, Van Essen E, Heine RJ, Nijpels G, Jahangir Tafrechi RS, Raap AK, Janssen GM, Lemkes HH. Mitochondrial diabetes: Molecular mechanisms and clinical presentation. Diabetes. 2004;53 Suppl 1:S103–9.

Imasawa T, Kitamura H, Kawaguchi T, Yatsuka Y, Okazaki Y, Murayama K. Changes in histopathology and heteroplasmy rates over 8 years and effectiveness of taurine supplementation in a patient with mitochondrial nephropathy caused by MT-TL1 mutation: A case report. Heliyon. 2023;9: e14923.

Article  PubMed  PubMed Central  Google Scholar 

Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–95.

Article  PubMed  Google Scholar 

Zhang M, Izumi I, Kagamimori S, Sokejima S, Yamagami T, Liu Z, Qi B. Role of taurine supplementation to prevent exercise-induced oxidative stress in healthy young men. Amino Acids. 2004;26:203–7.

Article  CAS  PubMed  Google Scholar 

Rikimaru M, Ohsawa Y, Wolf AM, Nishimaki K, Ichimiya H, Kamimura N, Nishimatsu S, Ohta S, Sunada Y. Taurine ameliorates impaired the mitochondrial function and prevents stroke-like episodes in patients with MELAS. Intern Med. 2012;51:3351–7.

Article  PubMed  Google Scholar 

Beyranvand MR, Khalafi MK, Roshan VD, Choobineh S, Parsa SA, Piranfar MA. Effect of taurine supplementation on exercise capacity of patients with heart failure. J Cardiol. 2011;57:333–7.

Article  PubMed  Google Scholar 

Jung BC, Laidlaw SA, Kopple JD. Taurine levels in plasma and blood cells in patients undergoing routine maintenance hemodialysis. Am J Kidney Dis. 1991;18:74–9.

Article  CAS  PubMed  Google Scholar 

Suliman ME, Bárány P, Filho JCD, Lindholm B, Bergström J. Accumulation of taurine in patients with renal failure. Nephrol Dial Transplant. 2002;17:528–9.

Article  PubMed  Google Scholar